|
| 37526368 | Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure. | Int J Radiat Biol | 2024 |
| 36282298 | [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer. | Eur J Nucl Med Mol Imaging | 2023 |
| 37606858 | [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab. | Eur J Nucl Med Mol Imaging | 2023 |
| 36958855 | Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT. | J Nucl Med | 2023 |
| 37256301 | Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity. | Strahlenther Onkol | 2023 |
| 37142345 | European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. | Lancet Haematol | 2023 |
| 36522184 | Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem. | J Nucl Med | 2023 |
| 34531263 | A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies. | J Nucl Med | 2022 |
| 35710733 | <sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients. | J Nucl Med | 2022 |
| 35606338 | Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study. | Hematol Oncol | 2022 |
| 35398521 | Clinical and technical challenges of cancer reirradiation: Words of wisdom. | Crit Rev Oncol Hematol | 2022 |
| 35724648 | Quantitative assessment of radionuclide production yields in in-beam and offline PET measurements at different proton irradiation facilities. | Phys Med Biol | 2022 |
| 35395657 | Improved 3D tumour definition and quantification of uptake in simulated lung tumours using deep learning. | Phys Med Biol | 2022 |
| 35489628 | Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging. | Semin Cancer Biol | 2022 |
| 35618476 | Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines). | J Nucl Med | 2022 |
| 35875934 | Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure. | Head Neck | 2022 |
| 35063892 | Clever Hans effect found in a widely used brain tumour MRI dataset. | Med Image Anal | 2022 |
| 34933890 | Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer <sup>18</sup>F-FDG PET Radiomics. | J Nucl Med | 2022 |
| 35302238 | Voxel-wise supervised analysis of tumors with multimodal engineered features to highlight interpretable biological patterns. | Med Phys | 2022 |
| 34519888 | An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients. | Eur J Nucl Med Mol Imaging | 2022 |
| 34740952 | Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development. | J Nucl Med | 2022 |
| 32532925 | Deep-Learning <sup>18</sup>F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma. | J Nucl Med | 2021 |
| 33674891 | Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer. | Eur J Nucl Med Mol Imaging | 2021 |
| 33774685 | Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. | Eur J Nucl Med Mol Imaging | 2021 |
| 33771905 | The T.R.U.E. Checklist for Identifying Impactful Artificial Intelligence-Based Findings in Nuclear Medicine: Is It True? Is It Reproducible? Is It Useful? Is It Explainable? | J Nucl Med | 2021 |
| 34439152 | New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT. | Cancers (Basel) | 2021 |
| 34729627 | Imaging translocator protein expression with positron emission tomography. | Eur J Nucl Med Mol Imaging | 2021 |
| 34537132 | Radiomics in PET Imaging:: A Practical Guide for Newcomers. | PET Clin | 2021 |
| 34207102 | Comment on Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. <i>Cancers</i> 2021, <i>13</i>, 1848. | Cancers (Basel) | 2021 |
| 34081153 | New PET technologies - embracing progress and pushing the limits. | Eur J Nucl Med Mol Imaging | 2021 |
| 33334910 | Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen. | J Nucl Med | 2021 |
| 33180226 | A radiomics pipeline dedicated to Breast MRI: validation on a multi-scanner phantom study. | MAGMA | 2021 |
| 33068741 | Potentials and caveats of AI in hybrid imaging. | Methods | 2021 |
| 32975661 | How can we combat multicenter variability in MR radiomics? Validation of a correction procedure. | Eur Radiol | 2021 |
| 31201248 | <sup>18</sup>F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome. | J Nucl Med | 2020 |
| 32083003 | Correction for Magnetic Field Inhomogeneities and Normalization of Voxel Values Are Needed to Better Reveal the Potential of MR Radiomic Features in Lung Cancer. | Front Oncol | 2020 |
| 32154773 | The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. | Radiology | 2020 |
| 32211931 | Longitudinal mouse-PET imaging: a reliable method for estimating binding parameters without a reference region or blood sampling. | Eur J Nucl Med Mol Imaging | 2020 |
| 30694160 | Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics. | Radiology | 2019 |
| 31780708 | A downsampling strategy to assess the predictive value of radiomic features. | Sci Rep | 2019 |
| 31240329 | EJNMMI supplement: bringing AI and radiomics to nuclear medicine. | Eur J Nucl Med Mol Imaging | 2019 |
| 31176599 | Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50]. | Drug Alcohol Depend | 2019 |
| 31455785 | PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity. | Sci Rep | 2019 |
| 31541033 | The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results. | J Nucl Med | 2019 |
| 28775204 | Impact of Endothelial 18-kDa Translocator Protein on the Quantification of <sup>18</sup>F-DPA-714. | J Nucl Med | 2018 |
| 29959149 | LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. | Cancer Res | 2018 |
| 30064704 | Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges. | Int J Radiat Oncol Biol Phys | 2018 |
| 30112113 | Influence of age on radiomic features in <sup>18</sup>F-FDG PET in normal breast tissue and in breast cancer tumors. | Oncotarget | 2018 |
| 30415015 | Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. | J Control Release | 2018 |
| 29672844 | Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows. | Epilepsia | 2018 |